vs
Side-by-side financial comparison of AMERISAFE INC (AMSF) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
AMERISAFE INC is the larger business by last-quarter revenue ($80.1M vs $76.2M, roughly 1.1× VIEMED HEALTHCARE, INC.). AMERISAFE INC runs the higher net margin — 10.2% vs 7.4%, a 2.8% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 10.3%). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 2.8%).
AMERISAFE Inc. is a specialty insurance provider that focuses exclusively on workers' compensation coverage for small and mid-sized businesses in high-hazard industries including construction, logging, trucking, and manufacturing. It operates across 49 U.S. states, offering tailored insurance policies paired with targeted risk management support for clients.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
AMSF vs VMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $80.1M | $76.2M |
| Net Profit | $8.1M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | — | 11.0% |
| Net Margin | 10.2% | 7.4% |
| Revenue YoY | 10.3% | 25.5% |
| Net Profit YoY | -9.0% | 30.7% |
| EPS (diluted) | $0.43 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $80.1M | — | ||
| Q4 25 | $81.6M | $76.2M | ||
| Q3 25 | $82.0M | $71.9M | ||
| Q2 25 | $81.1M | $63.1M | ||
| Q1 25 | $72.6M | $59.1M | ||
| Q4 24 | $74.0M | $60.7M | ||
| Q3 24 | $78.7M | $58.0M | ||
| Q2 24 | $75.8M | $55.0M |
| Q1 26 | $8.1M | — | ||
| Q4 25 | $10.4M | $5.6M | ||
| Q3 25 | $13.8M | $3.5M | ||
| Q2 25 | $14.0M | $3.2M | ||
| Q1 25 | $8.9M | $2.6M | ||
| Q4 24 | $13.2M | $4.3M | ||
| Q3 24 | $14.3M | $3.9M | ||
| Q2 24 | $11.0M | $1.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% |
| Q1 26 | — | — | ||
| Q4 25 | 15.6% | 11.0% | ||
| Q3 25 | 21.3% | 7.8% | ||
| Q2 25 | 21.5% | 8.1% | ||
| Q1 25 | 15.5% | 6.5% | ||
| Q4 24 | 22.7% | 10.6% | ||
| Q3 24 | 22.6% | 9.7% | ||
| Q2 24 | 18.1% | 6.6% |
| Q1 26 | 10.2% | — | ||
| Q4 25 | 12.8% | 7.4% | ||
| Q3 25 | 16.9% | 4.9% | ||
| Q2 25 | 17.2% | 5.0% | ||
| Q1 25 | 12.3% | 4.4% | ||
| Q4 24 | 17.8% | 7.1% | ||
| Q3 24 | 18.2% | 6.7% | ||
| Q2 24 | 14.5% | 2.7% |
| Q1 26 | $0.43 | — | ||
| Q4 25 | $0.55 | $0.14 | ||
| Q3 25 | $0.72 | $0.09 | ||
| Q2 25 | $0.73 | $0.08 | ||
| Q1 25 | $0.47 | $0.06 | ||
| Q4 24 | $0.69 | $0.10 | ||
| Q3 24 | $0.75 | $0.10 | ||
| Q2 24 | $0.57 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.2M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $246.6M | $141.5M |
| Total Assets | — | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $34.2M | — | ||
| Q4 25 | $61.9M | $13.5M | ||
| Q3 25 | $54.7M | $11.1M | ||
| Q2 25 | $48.5M | $20.0M | ||
| Q1 25 | $44.8M | $10.2M | ||
| Q4 24 | $44.1M | $17.5M | ||
| Q3 24 | $63.7M | $11.3M | ||
| Q2 24 | $30.6M | $8.8M |
| Q1 26 | $246.6M | — | ||
| Q4 25 | $251.6M | $141.5M | ||
| Q3 25 | $274.8M | $133.6M | ||
| Q2 25 | $265.6M | $139.7M | ||
| Q1 25 | $260.8M | $134.8M | ||
| Q4 24 | $257.3M | $131.4M | ||
| Q3 24 | $314.4M | $125.0M | ||
| Q2 24 | $301.0M | $119.4M |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $199.2M | ||
| Q3 25 | $1.2B | $202.4M | ||
| Q2 25 | $1.2B | $184.6M | ||
| Q1 25 | $1.2B | $178.1M | ||
| Q4 24 | $1.2B | $177.1M | ||
| Q3 24 | $1.3B | $169.5M | ||
| Q2 24 | $1.2B | $163.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $18.4M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $11.1M | $18.4M | ||
| Q3 25 | $10.7M | $18.4M | ||
| Q2 25 | $-8.4M | $12.3M | ||
| Q1 25 | $-1.8M | $2.9M | ||
| Q4 24 | $24.2M | $15.0M | ||
| Q3 24 | $8.4M | $12.7M | ||
| Q2 24 | $-2.6M | $10.2M |
| Q1 26 | — | — | ||
| Q4 25 | $8.9M | $9.7M | ||
| Q3 25 | $9.8M | $10.7M | ||
| Q2 25 | $-9.5M | $4.1M | ||
| Q1 25 | $-1.8M | $-12.6M | ||
| Q4 24 | $23.4M | $3.2M | ||
| Q3 24 | $8.4M | $1.7M | ||
| Q2 24 | $-2.6M | $1.2M |
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | 12.7% | ||
| Q3 25 | 11.9% | 14.9% | ||
| Q2 25 | -11.7% | 6.5% | ||
| Q1 25 | -2.5% | -21.4% | ||
| Q4 24 | 31.5% | 5.2% | ||
| Q3 24 | 10.7% | 3.0% | ||
| Q2 24 | -3.5% | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | 2.6% | 11.5% | ||
| Q3 25 | 1.1% | 10.6% | ||
| Q2 25 | 1.3% | 12.9% | ||
| Q1 25 | 0.0% | 26.2% | ||
| Q4 24 | 1.1% | 19.5% | ||
| Q3 24 | 0.0% | 19.0% | ||
| Q2 24 | 0.1% | 16.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.06× | 3.27× | ||
| Q3 25 | 0.77× | 5.23× | ||
| Q2 25 | -0.61× | 3.88× | ||
| Q1 25 | -0.20× | 1.09× | ||
| Q4 24 | 1.83× | 3.47× | ||
| Q3 24 | 0.59× | 3.29× | ||
| Q2 24 | -0.24× | 6.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
